
Luis Lara-Mejía/X
Apr 15, 2025, 12:08
Luis Lara-Mejía: Oncogenic fusions represent a diagnostic challenge across solid tumors
Luis Lara-Mejía, Medical Oncologist Specialized in Thoracic Neoplasms at National Institute of Cancerology, posted on X:
“Oncogenic fusions represent a diagnostic challenge across solid tumors.
This excellent review discusses the evolution of molecular platforms, pitfalls of current assays, and the future of fusion detection for precision oncology.
A must-read for molecular pathologists and oncologists.”
“Oncogenic gene fusions in cancer: from biology to therapy.”
Authors: Stephen V. Liu, Misako Nagasaka, Judith Atz, Flavio Solca and Leonhard Müllauer
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 17, 2025, 11:25
Apr 17, 2025, 10:30
Apr 17, 2025, 10:14
Apr 17, 2025, 10:01
Apr 17, 2025, 09:54